𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Safety and immunogenicity of a defined vaccine for the prevention of cutaneous leishmaniasis

✍ Scribed by Iván D. Vélez; Katherine Gilchrist; Sofía Martínez; José R. Ramírez-Pineda; Jill A. Ashman; Fabiana P. Alves; Rhea N. Coler; Lisa Y. Bogatzki; Stuart J. Kahn; Anna Marie Beckmann; Karen D. Cowgill; Steven G. Reed; Franco M. Piazza

Book ID
116962141
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
481 KB
Volume
28
Category
Article
ISSN
0264-410X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and immunogenicity of a killed Le
Safety and immunogenicity of a killed Leishmania (L.) amazonensis vaccine against cutaneous leishmaniasis in Colombia: a randomized controlled trial
✍ Ivan Dario Vélez; Sonia del Pilar Agudelo; Maria Patricia Arbelaez; Katherine Gi 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 699 KB

The safety and immunogenicity of an intramuscular (i.m.) and intradermal (ID) formulation of autoclaved Leishmania (Leishmania) amazonensis vaccine was evaluated in 296 volunteers in a randomized, placebo-controlled, double-blind trial in Colombia. There were 4 vaccination groups: i.m. vaccine, i.m.

Safety and immunogenicity of a recombina
Safety and immunogenicity of a recombinant hepatitis B vaccine
✍ E. Dandolos; A. Roumeliotou-Karayannis; S. C. Richardson; Prof. G. Papaevangelou 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 340 KB

A hepatitis B vaccine produced in yeast by recombinant DNA technology was evaluated using 5-micrograms and 10-micrograms doses in a randomized trial lasting 7 months in 110 male armed forces recruits aged 17-19 years. Results were compared to those of an identical trial of a plasma-derived vaccine.